{"id":11838,"date":"2022-10-14T09:40:33","date_gmt":"2022-10-14T04:10:33","guid":{"rendered":"http:\/\/finservwealth.com\/us-supreme-court-rebuffs-novartis-allows-generic-versions-of-ms-drug\/"},"modified":"2022-10-14T09:40:33","modified_gmt":"2022-10-14T04:10:33","slug":"us-supreme-court-rebuffs-novartis-allows-generic-versions-of-ms-drug","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/us-supreme-court-rebuffs-novartis-allows-generic-versions-of-ms-drug\/","title":{"rendered":"US Supreme Court rebuffs Novartis, allows generic versions of MS drug"},"content":{"rendered":"<p> Novartis had asked the justices to suspend a lower court#39;s ruling that lifted a ban on generic versions of Gilenya, the Switzerland-based company#39;s third highest-selling drug last year with $2.8 billion in sales.<\/p><div id=\"finse-1210612200\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/world-news\/us-supreme-court-rebuffs-novartis-allows-generic-versionsms-drug_16654181.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Novartis had asked the justices to suspend a lower court#39;s ruling that lifted a ban on generic versions of Gilenya, the Switzerland-based company#39;s third highest-selling drug last year with $2.8 billion in sales. Read More<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-11838","post","type-post","status-publish","format-standard","hentry","category-latest-news"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/11838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=11838"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/11838\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=11838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=11838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=11838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}